The Logic of "Watch and Wait"

If you have been told you have CLL or SLL but do not need treatment yet, you are entering a phase officially called active surveillance. However, because this period involves living with cancer without actively fighting it with medication, it can feel incredibly stressful ^[1][2].

It is important to understand that “watching and waiting” is not the same as “doing nothing.” It is a deliberate, evidence-based strategy designed to protect you from the side effects of powerful medicines until the benefits of those medicines clearly outweigh their risks ^[3][2].

The Evidence for Waiting

It may seem counterintuitive to leave cancer untreated, but for CLL/SLL, early treatment has never been shown to improve overall survival for patients without symptoms ^[4][5].

A major study called the CLL12 trial recently looked at this. Researchers gave one group of early-stage, asymptomatic patients a targeted drug and another group a placebo ^[4]. While the drug delayed the cancer from growing, it did not improve overall survival ^[4][6]. Furthermore, those who took the drug early faced more side effects, including heart-related issues, compared to those who just waited ^[4]. Routine early treatment exposes you to toxicity without a proven lifespan benefit.

The iwCLL Triggers: When Does Waiting End?

Doctors use a standardized set of rules created by the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) to decide exactly when it is time to transition from watching to treating ^[3][7]. You generally only start treatment if you meet one of these “active disease” criteria:

1. Progressive Bone Marrow Failure: This occurs when the CLL cells crowd out your healthy blood cells in the marrow. It is typically defined as progressively worsening anemia (often a hemoglobin level dropping below 10 g/dL) or thrombocytopenia (platelets dropping below 100,000/µL) ^[7]. (Note: Autoimmune causes of low blood counts are handled differently).
2. Massive or Symptomatic Lumps: Treatment is indicated if lymph nodes become massive (e.g., 10 cm or larger), or if they are rapidly progressive or causing pain. An enlarged spleen that causes discomfort or early fullness when eating is also a trigger ^[7][NCT05536349].
3. Rapidly Rising White Counts: If your absolute lymphocyte count (ALC) increases by more than 50% in two months or doubles in less than six months, it may be a sign the disease is accelerating ^[7][NCT06544785].
4. Severe “B-Symptoms”: These are constitutional symptoms that significantly impact your daily life, such as:
   • Unexplained weight loss (more than 10% of your body weight in 6 months) ^[7].
   • Drenching night sweats that require changing clothes or bedding for more than a month ^[7].
   • Unexplained fevers higher than 100.4°F (38°C) for at least two weeks (without an infection) ^[7].
   • Fatigue so severe that you cannot perform your usual work or daily activities ^[7][NCT06544785].

Importantly, a single lab value usually does not dictate treatment on its own. Your doctor will look at the whole clinical picture.

Coping with Active Surveillance

The psychological toll of active surveillance is a documented medical concern. Many patients report elevated levels of stress, anxiety, and social isolation during this phase ^[2][1].

To manage the stress, experts suggest the following strategies:

• Establish Continuity: Seeing the same hematologist at every visit can provide a sense of stability and trust ^[1].
• Focus on Trends, Not Numbers: A single blood test can fluctuate due to a minor cold or stress. Look at your blood counts over several months to see the true “direction” of the disease ^[7].
• Routine Distress Screening: If your anxiety is interfering with your sleep, appetite, or ability to enjoy life, ask your doctor for a referral to a psycho-oncologist or a counselor who specializes in chronic illness ^[2][1].